Multidrug resistance (MDR) in acute myeloid leukemia (AML) with core-binding factor (CBF) abnormalities.

被引：0
|
作者：
Baer, MR [1 ]
O'Loughlin, KL [1 ]
Minderman, H [1 ]
Sait, SN [1 ]
Flood, JJ [1 ]
Sorci, JJ [1 ]
Stewart, CC [1 ]
机构：
[1] Roswell Pk Canc Inst, Buffalo, NY 14263 USA
来源：
BLOOD | 1999年 / 94卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
273
引用
收藏
页码：64A / 64A
页数：1
相关论文
共 50 条
  • [41] No evidence for core-binding factor CBFβ as a leukemia predisposing factor in chromosome 16q22-linked familial AML
    Escher, R
    Hagos, F
    Michaud, J
    Sveen, L
    Horwitz, M
    Olopade, OI
    Scott, HS
    LEUKEMIA, 2004, 18 (04) : 881 - 881
  • [42] Additional Prognostic Impact of Specific Sites of Extramedullary Leukemia in Pediatric AML with MLL-Rearrangements but Not in Core-Binding Factor (CBF) AML
    Creutzig, Ursula
    Zimmermann, Martin
    Dworzak, Michael
    Bourquin, Jean-Pierre
    von Neuhoff, Christine
    Sander, Annette
    Stary, Jan
    Reinhardt, Dirk
    BLOOD, 2012, 120 (21)
  • [43] Genomic heterogeneity in core-binding factor acute myeloid leukemia and its clinical implication
    Jahn, Nikolaus
    Terzer, Tobias
    Straeng, Eric
    Dolnik, Anna
    Cocciardi, Sibylle
    Panina, Ekaterina
    Corbacioglu, Andrea
    Herzig, Julia
    Weber, Daniela
    Schrade, Anika
    Goetze, Katharina
    Schroeder, Thomas
    Luebbert, Michael
    Wellnitz, Dominique
    Koller, Elisabeth
    Schlenk, Richard F.
    Gaidzik, Verena, I
    Paschka, Peter
    Ruecker, Frank G.
    Heuser, Michael
    Thol, Felicitas
    Ganser, Arnold
    Benner, Axel
    Doehner, Hartmut
    Doehner, Konstanze
    Bullinger, Lars
    BLOOD ADVANCES, 2020, 4 (24) : 6342 - 6352
  • [44] The Clinical Implications and Outcomes of RAS Mutatome in Core-Binding Factor Acute Myeloid Leukemia
    Awada, Hassan
    Gurnari, Carmelo
    Meggendorfer, Manja
    Durmaz, Arda
    Kuzmanovic, Teodora
    Kerr, Cassandra
    Carraway, Hetty
    Nazha, Aziz
    Haferlach, Torsten
    Sekeres, Mikkael
    Visconte, Valeria
    Maciejewski, Jaroslaw
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2020, 20 : S186 - S186
  • [45] RNA Sequencing-Based Measurement of Fusion-Transcript for Minimal Residual Disease (MRD) Monitoring in Core-Binding Factor Acute Myeloid Leukemia (CBF-AML)
    Kim, Taehyung
    Moon, Joon Ho
    Ahn, Jae-Sook
    Tyndel, Marc S.
    Lee, Seung-Shin
    Ahn, Seo-Yeon
    Jung, Sung-Hoon
    Yang, Deok-Hwan
    Lee, Je-Jung
    Choi, Seunghyun
    Lee, Ja-yeon
    Lee, Yoojin
    Sohn, Sang Kyun
    Zhang, Zhaolei
    Kim, Hyeoung-Joon
    Kim, Dennis Dong Hwan
    BLOOD, 2018, 132
  • [46] Core-binding factor acute myeloid leukemia: can we improve on HiDAC consolidation?
    Paschka, Peter
    Doehner, Konstanze
    HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM, 2013, : 209 - 219
  • [47] Core Binding Factor Acute Myeloid Leukemia of the Elderly Treated with Conventional Chemotherapy : A Collaborative Study of the French CBF AML Intergroup
    Prebet, Thomas
    Boissel, Nicolas
    Recher, Christian
    Thomas, Xavier
    Delaunay, Jacques
    Cahn, Jean-Yves
    Pigneux, Arnaud
    Quesnel, Bruno
    Witz, Francis
    Thepot, Sylvain
    Ugo, Valerie
    Terre, Christine
    Tavernier, Emmanuelle
    Castaigne, Sylvie
    Guilhot, Francois
    Dombret, Herve
    Vey, Norbert
    BLOOD, 2008, 112 (11) : 206 - 207
  • [48] The genomic landscape of core-binding factor acute myeloid leukemias
    Zachary J Faber
    Xiang Chen
    Amanda Larson Gedman
    Kristy Boggs
    Jinjun Cheng
    Jing Ma
    Ina Radtke
    Jyh-Rong Chao
    Michael P Walsh
    Guangchun Song
    Anna K Andersson
    Jinjun Dang
    Li Dong
    Yu Liu
    Robert Huether
    Zhongling Cai
    Heather Mulder
    Gang Wu
    Michael Edmonson
    Michael Rusch
    Chunxu Qu
    Yongjin Li
    Bhavin Vadodaria
    Jianmin Wang
    Erin Hedlund
    Xueyuan Cao
    Donald Yergeau
    Joy Nakitandwe
    Stanley B Pounds
    Sheila Shurtleff
    Robert S Fulton
    Lucinda L Fulton
    John Easton
    Evan Parganas
    Ching-Hon Pui
    Jeffrey E Rubnitz
    Li Ding
    Elaine R Mardis
    Richard K Wilson
    Tanja A Gruber
    Charles G Mullighan
    Richard F Schlenk
    Peter Paschka
    Konstanze Döhner
    Hartmut Döhner
    Lars Bullinger
    Jinghui Zhang
    Jeffery M Klco
    James R Downing
    Nature Genetics, 2016, 48 : 1551 - 1556
  • [49] The genomic landscape of core-binding factor acute myeloid leukemias
    Faber, Zachary J.
    Chen, Xiang
    Gedman, Amanda Larson
    Boggs, Kristy
    Cheng, Jinjun
    Ma, Jing
    Radtke, Ina
    Chao, Jyh-Rong
    Walsh, Michael P.
    Song, Guangchun
    Andersson, Anna K.
    Dang, Jinjun
    Dong, Li
    Liu, Yu
    Huether, Robert
    Call, Zhongling
    Mulder, Heather
    Wu, Gang
    Edmonson, Michael
    Rusch, Michael
    Qu, Chunxu
    Li, Yongjin
    Vadodaria, Bhavin
    Wang, Jianmin
    Hedlund, Erin
    Cao, Xueyuan
    Yergeau, Donald
    Nakitandwe, Joy
    Pounds, Stanley B.
    Shurtleff, Sheila
    Fulton, Robert S.
    Fulton, Lucinda L.
    Easton, John
    Parganas, Evan
    Pui, Ching-Hon
    Rubnitz, Jeffrey E.
    Dingo, Li
    Mardis, Elaine R.
    Wilson, Richard K.
    Gruber, Tanja A.
    Mullighan, Charles G.
    Schlenk, Richard F.
    Paschka, Peter
    Doehner, Konstanze
    Doehner, Hartmut
    Bullinger, Lars
    Zhang, Jinghui
    Klco, Jeffery M.
    Downing, James R.
    NATURE GENETICS, 2016, 48 (12) : 1551 - 1556
  • [50] Survival Is Poorer in Patients With Secondary Core-binding Factor Acute Myelogenous Leukemia Compared With De Novo Core-binding Factor Leukemia
    Borthakur, Gautam
    Lin, E.
    Jain, Nitin
    Estey, Elihu E.
    Cortes, Jorge E.
    O'Brien, Susan
    Faderl, Stefan
    Ravandi, Farhad
    Pierce, Sherry
    Kantarjian, Hagop
    CANCER, 2009, 115 (14) : 3217 - 3221
12345